abstract |
The present invention provides variant activin IIB soluble receptor polypeptides and proteins capable of binding to and inhibiting the activity of activin A, myostatin or GDF-11. The present invention also provides polynucleotides, vectors and host cells capable of producing variant polypeptides and proteins. Also provided are compositions and methods for treating muscle wasting and other diseases and disorders. |